Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$437.42 - $470.64 $1.49 Million - $1.6 Million
3,400 New
3,400 $1.57 Million
Q4 2022

Feb 14, 2023

BUY
$346.68 - $397.58 $312,012 - $357,822
900 Added 15.25%
6,800 $2.55 Million
Q3 2022

Nov 14, 2022

BUY
$321.25 - $373.84 $1.9 Million - $2.21 Million
5,900 New
5,900 $2.01 Million
Q1 2022

May 16, 2022

SELL
$244.61 - $310.48 $1.71 Million - $2.17 Million
-7,000 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$198.21 - $248.9 $1.31 Million - $1.64 Million
6,600 Added 1650.0%
7,000 $1.74 Million
Q2 2021

Aug 16, 2021

SELL
$184.89 - $202.68 $258,845 - $283,752
-1,400 Reduced 77.78%
400 $76,000
Q4 2020

Feb 16, 2021

SELL
$143.79 - $183.66 $704,571 - $899,934
-4,900 Reduced 73.13%
1,800 $313,000
Q4 2019

Feb 14, 2020

BUY
$130.23 - $153.27 $195,344 - $229,905
1,500 Added 28.85%
6,700 $927,000
Q2 2019

Aug 14, 2019

SELL
$112.47 - $134.93 $1.23 Million - $1.47 Million
-10,900 Reduced 67.7%
5,200 $699,000
Q1 2019

May 15, 2019

BUY
$111.86 - $136.3 $1.39 Million - $1.69 Million
12,400 Added 335.14%
16,100 $1.89 Million
Q4 2018

Feb 14, 2019

SELL
$108.23 - $136.84 $692,672 - $875,776
-6,400 Reduced 63.37%
3,700 $409,000
Q3 2018

Nov 14, 2018

SELL
$123.14 - $138.52 $2.08 Million - $2.34 Million
-16,900 Reduced 62.59%
10,100 $1.34 Million
Q2 2018

Aug 14, 2018

BUY
$133.4 - $158.13 $280,140 - $332,073
2,100 Added 8.43%
27,000 $3.6 Million
Q1 2018

May 15, 2018

BUY
$138.75 - $176.72 $1.35 Million - $1.71 Million
9,700 Added 63.82%
24,900 $3.51 Million
Q4 2017

Feb 14, 2018

SELL
$135.02 - $162.6 $6.13 Million - $7.38 Million
-45,400 Reduced 74.92%
15,200 $2.37 Million
Q3 2017

Nov 14, 2017

BUY
$146.0 - $161.87 $8.85 Million - $9.81 Million
60,600
60,600 $9.31 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $90.3B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.